Banque Pictet & Cie SA lifted its holdings in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 5.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,572 shares of the medical device company’s stock after purchasing an additional 2,096 shares during the period. Banque Pictet & Cie SA owned about 0.08% of Cooper Companies, Inc. (The) worth $9,857,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in COO. Janus Henderson Group PLC raised its stake in shares of Cooper Companies, Inc. (The) by 558.5% during the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock worth $520,937,000 after purchasing an additional 1,845,368 shares during the period. Pioneer Investment Management Inc. raised its stake in shares of Cooper Companies, Inc. (The) by 136.6% during the 2nd quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock worth $293,589,000 after purchasing an additional 708,028 shares during the period. Koch Industries Inc. bought a new stake in shares of Cooper Companies, Inc. (The) during the 2nd quarter worth $312,000. Voya Investment Management LLC raised its stake in shares of Cooper Companies, Inc. (The) by 973.4% during the 2nd quarter. Voya Investment Management LLC now owns 329,015 shares of the medical device company’s stock worth $78,773,000 after purchasing an additional 298,363 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of Cooper Companies, Inc. (The) during the 2nd quarter worth $71,050,000. Institutional investors own 96.71% of the company’s stock.

A number of brokerages recently issued reports on COO. Robert W. Baird restated a “buy” rating and issued a $273.00 price objective (up from $267.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 price objective on the stock in a research note on Tuesday, August 29th. Jefferies Group LLC set a $250.00 price objective on Cooper Companies, Inc. (The) and gave the company a “buy” rating in a research note on Thursday, August 17th. Oppenheimer Holdings, Inc. restated a “hold” rating and issued a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Finally, Cleveland Research restated a “buy” rating on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, August 22nd. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $260.22.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: This report was originally reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/17/cooper-companies-inc-the-coo-stake-raised-by-banque-pictet-cie-sa.html.

Shares of Cooper Companies, Inc. (COO) traded up $4.79 on Friday, hitting $239.45. The stock had a trading volume of 189,800 shares, compared to its average volume of 426,284. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39. The company has a market capitalization of $11,482.39, a PE ratio of 25.09, a PEG ratio of 2.01 and a beta of 0.55. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.29 and a current ratio of 2.51.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The firm had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same period in the prior year, the business posted $2.30 earnings per share. The company’s revenue was up 8.0% on a year-over-year basis. equities analysts expect that Cooper Companies, Inc. will post 9.72 earnings per share for the current year.

Cooper Companies, Inc. (The) Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.